Understanding the PH Drug Pipeline

Over the past few decades, there has been enormous growth in our understanding of pulmonary arterial hypertension (PAH), how it progresses and therapies available to patients. But much more research is needed to find ways to improve the quality of life for people living with PH. Pulmonologist Anna Hemnes provides insight on the available PAH therapies, the biological pathways targeted and new treatments in the drug development pipeline.

Diamond Sponsor

Gold Sponsors

United Therapeutics

Silver Sponsor

General Sponsors

PHriends Sponsors